Skip to main content
Premium Trial:

Request an Annual Quote

Sophia Genetics, Genomenon to Integrate Genomic Analysis, Search Engine Platforms

NEW YORK – Genomenon said today it has partnered with Sophia Genetics to incorporate the Mastermind Genomic Search Engine into the Sophia artificial intelligence platform and Alamut Suite for genomic analysis. 

Under the new comarketing and distribution agreement, users will be able to apply both technologies to rapidly access genomic evidence linked to human variants, reducing the time needed to interpret a variant and examine its pathogenicity. 

Sophia, which is headquartered in Saint Sulpice, Switzerland with a US office in Boston, has developed a machine learning tool that helps healthcare professionals detect and characterize genomic variants linked to cancers and hereditary disorders. The firm's Alamut Suite is a genome browser that graphically displays complex genetic information and assesses the pathogenic status of disease mutations. 

"This partnership will help experts better and more quickly assess the impact of accurately detected genomic variants in a clinical context," Gioia Althoff, senior VP of Genomics at Sophia, said in a statement.

Financial details were undisclosed.

"The broader adoption of Genomenon's Mastermind provides significant value to our fast-growing customer base around the world," Genomenon CEO Mike Klein said in a statement. 

Genomenon previously partnered with Congenica to incorporate Mastermind into Congenica's clinical decision support platform. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.